Visceral Steatosis  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00013598: Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Completed
2
30
US
Pioglitazone
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Fatty Liver, Nonalcoholic Steatohepatitis
 
03/04
NCT00441272: Pioglitazone to Treat Fatty Liver in People With HIV Infection

Completed
2
100
US
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, Hepatic Steatosis, Insulin Resistance
10/08
 
NCT00062764: Treating Nonalcoholic Steatohepatitis With Pioglitazone

Completed
2
18
US
Actos (Pioglitazone)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hepatitis
02/09
02/09
NCT01703260: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

Terminated
2
20
US
Roflumilast, Daxas, Daliresp, Pioglitazone, Actos, Placebo
AstraZeneca
Nonalcoholic Steatohapatitis
09/14
09/14

Download Options